{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T13:32:33Z","timestamp":1774445553718,"version":"3.50.1"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Cuiying Scientific and Technological Innovation Program of The Second Hospital & Clinical Medical School, Lanzhou University","award":["CY2023-BJ-09"],"award-info":[{"award-number":["CY2023-BJ-09"]}]},{"name":"the Cuiying Scientific and Technological Innovation Program of The Second Hospital & Clinical Medical School, Lanzhou University","award":["CY2023-BJ-09"],"award-info":[{"award-number":["CY2023-BJ-09"]}]},{"name":"the Cuiying Scientific and Technological Innovation Program of The Second Hospital & Clinical Medical School, Lanzhou University","award":["CY2023-BJ-09"],"award-info":[{"award-number":["CY2023-BJ-09"]}]},{"name":"the Cuiying Scientific and Technological Innovation Program of The Second Hospital & Clinical Medical School, Lanzhou University","award":["CY2023-BJ-09"],"award-info":[{"award-number":["CY2023-BJ-09"]}]},{"name":"the Cuiying Scientific and Technological Innovation Program of The Second Hospital & Clinical Medical School, Lanzhou University","award":["CY2023-BJ-09"],"award-info":[{"award-number":["CY2023-BJ-09"]}]},{"name":"the Cuiying Scientific and Technological Innovation Program of The Second Hospital & Clinical Medical School, Lanzhou University","award":["CY2023-BJ-09"],"award-info":[{"award-number":["CY2023-BJ-09"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Brain"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Reversible disruption of the blood-brain barrier (BBB) occurs within hours after the onset of ischemic stroke (IS), offering a critical window for therapeutic intervention. However, the molecular characteristics and their potential as circulating biomarkers associated with this transient phase of BBB dysfunction remain poorly defined. To elucidate these mechanisms, we employed an oxygen-glucose deprivation (OGD) model in human cerebral microvascular endothelial cells (hCMEC\/D3) to simulate early ischemic stress, and systematically profiled their secreted proteome and metabolome. By comparing with non-brain-derived human umbilical vein endothelial cells (HUVECs), we identified brain endothelium-specific hypoxic response signatures. These molecules were significantly enriched in pathways related to metabolic reprogramming, antioxidant defense, and epigenetic regulation pathways, indicating a coordinated adaptive response to preserve BBB homeostasis. Furthermore, integrative multi-omics analysis revealed 14 protein-metabolite pairs with potential functional synergy. Based on a multi-criteria screening strategy including brain specificity, functional relevance, and secretory potential, we prioritized 10 candidate circulating biomarkers: ALDH2, ITGA5, KYNU, TFRC, CD44, COL1A2, HEXB, HSPG2, THBS4, and DLD. Preliminary validation using serum from acute IS (AIS) patients and healthy controls showed significantly altered levels of ALDH2, ITGA5, KYNU, and TFRC, with TFRC exhibiting promising diagnostic performance both individually (AUC\u2009=\u20090.816) and in combination with the other three biomarkers (AUC\u2009=\u20090.876). Moreover, multivariate logistic regression analysis revealed that elevated TFRC was independently associated with poor 90-day outcomes (OR\u2009=\u20091.02, 95% CI 1.00\u20131.04,\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.031), while higher DLD levels were correlated with good prognosis (OR\u2009=\u20090.68, 95% CI 0.39\u20130.90,\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.047). Notably, TFRC expression was upregulated in hCMEC\/D3 cells under early hypoxic stress, while its extracellular secretion was reduced. This observation suggests a potential early cellular adaptation to preserve iron homeostasis. In summary, these findings uncover early molecular adaptations of brain microvascular endothelial cells to ischemic stress and propose a panel of secreted biomarkers with translational potential for early diagnosis and outcome prediction in IS, potentially guiding the development of time-sensitive therapeutic strategies.\n                  <\/jats:p>","DOI":"10.1186\/s13041-026-01283-5","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T11:36:34Z","timestamp":1771241794000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Early hypoxia-induced secretome remodeling reveals adaptive mechanisms and biomarkers of blood-brain barrier dysfunction in ischemic stroke"],"prefix":"10.1186","volume":"19","author":[{"given":"Qian","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingling","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingqiang","family":"Dang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chongge","family":"You","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,16]]},"reference":[{"key":"1283_CR1","doi-asserted-by":"publisher","first-page":"e137","DOI":"10.1212\/WNL.0000000000207387","volume":"101","author":"J Fan","year":"2023","unstructured":"Fan J, Li X, Yu X, Liu Z, Jiang Y, Fang Y, et al. Global burden, risk factor analysis, and prediction study of ischemic stroke, 1990\u20132030. Neurology. 2023;101:e137\u201350.","journal-title":"Neurology"},{"key":"1283_CR2","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1016\/j.amjmed.2021.07.027","volume":"134","author":"SK Feske","year":"2021","unstructured":"Feske SK. Ischemic stroke. Am J Med. 2021;134:1457\u201364.","journal-title":"Am J Med"},{"key":"1283_CR3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.neuron.2017.07.030","volume":"96","author":"C Iadecola","year":"2017","unstructured":"Iadecola C. The neurovascular unit coming of age: a journey through neurovascular coupling in health and disease. Neuron. 2017;96:17\u201342.","journal-title":"Neuron"},{"key":"1283_CR4","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.cell.2015.10.067","volume":"163","author":"Z Zhao","year":"2015","unstructured":"Zhao Z, Nelson AR, Betsholtz C, Zlokovic BV. Establishment and dysfunction of the Blood-Brain barrier. Cell. 2015;163:1064\u201378.","journal-title":"Cell"},{"key":"1283_CR5","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13041-022-00937-4","volume":"15","author":"HK Alajangi","year":"2022","unstructured":"Alajangi HK, Kaur M, Sharma A, Rana S, Thakur S, Chatterjee M, et al. Blood-brain barrier: emerging trends on transport models and new-age strategies for therapeutics intervention against neurological disorders. Mol Brain. 2022;15:49.","journal-title":"Mol Brain"},{"key":"1283_CR6","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1111\/jon.12225","volume":"25","author":"M Giraud","year":"2015","unstructured":"Giraud M, Cho TH, Nighoghossian N, Maucort-Boulch D, Deiana G, \u00d8stergaard L, et al. Early blood brain barrier changes in acute ischemic stroke: a sequential MRI study. J Neuroimaging. 2015;25:959\u201363.","journal-title":"J Neuroimaging"},{"key":"1283_CR7","doi-asserted-by":"publisher","first-page":"104621","DOI":"10.1016\/j.mvr.2023.104621","volume":"151","author":"K Mathias","year":"2024","unstructured":"Mathias K, Machado RS, Stork S, Dos Santos D, Joaquim L, Generoso J, et al. Blood-brain barrier permeability in the ischemic stroke: an update. Microvasc Res. 2024;151:104621.","journal-title":"Microvasc Res"},{"key":"1283_CR8","doi-asserted-by":"publisher","first-page":"3323","DOI":"10.1161\/STROKEAHA.110.608257","volume":"42","author":"Y Yang","year":"2011","unstructured":"Yang Y, Rosenberg GA. Blood-brain barrier breakdown in acute and chronic cerebrovascular disease. Stroke. 2011;42:3323\u20138.","journal-title":"Stroke"},{"key":"1283_CR9","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s00415-025-12888-6","volume":"272","author":"A Kleeberg","year":"2025","unstructured":"Kleeberg A, Luft T, Golkowski D, Purrucker JC. Endothelial dysfunction in acute ischemic stroke: a review. J Neurol. 2025;272:143.","journal-title":"J Neurol"},{"key":"1283_CR10","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1152\/physrev.00050.2017","volume":"99","author":"MD Sweeney","year":"2019","unstructured":"Sweeney MD, Zhao Z, Montagne A, Nelson AR, Zlokovic BV. Blood-Brain barrier: from physiology to disease and back. Physiol Rev. 2019;99:21\u201378.","journal-title":"Physiol Rev"},{"key":"1283_CR11","doi-asserted-by":"publisher","first-page":"e140966","DOI":"10.1172\/JCI140966","volume":"131","author":"NE Propson","year":"2021","unstructured":"Propson NE, Roy ER, Litvinchuk A, K\u00f6hl J, Zheng H. Endothelial C3a receptor mediates vascular inflammation and blood-brain barrier permeability during aging. J Clin Invest. 2021;131:e140966.","journal-title":"J Clin Invest"},{"key":"1283_CR12","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1161\/01.RES.0000255691.76142.4a","volume":"100","author":"WC Aird","year":"2007","unstructured":"Aird WC. Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circ Res. 2007;100:158\u201373.","journal-title":"Circ Res"},{"key":"1283_CR13","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jconrel.2023.04.020","volume":"358","author":"D Qi","year":"2023","unstructured":"Qi D, Lin H, Hu B, Wei Y. A review on in vitro model of the blood-brain barrier (BBB) based on hCMEC\/D3 cells. J Control Release. 2023;358:78\u201397.","journal-title":"J Control Release"},{"key":"1283_CR14","doi-asserted-by":"publisher","first-page":"938","DOI":"10.3390\/app10030938","volume":"10","author":"DJ Medina-Leyte","year":"2020","unstructured":"Medina-Leyte DJ, Dom\u00ednguez-P\u00e9rez M, Mercado I, Villarreal-Molina MT, Jacobo-Albavera L. Use of human umbilical vein endothelial cells (HUVEC) as a model to study cardiovascular disease: A review. Appl Sci. 2020;10:938.","journal-title":"Appl Sci"},{"key":"1283_CR15","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/nm0809-828","volume":"15","author":"M May","year":"2009","unstructured":"May M. From cells, secrets of the secretome leak out. Nat Med. 2009;15:828.","journal-title":"Nat Med"},{"key":"1283_CR16","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jprot.2015.12.011","volume":"133","author":"V Llombart","year":"2016","unstructured":"Llombart V, Garc\u00eda-Berrocoso T, Bech-Serra JJ, Simats A, Bustamante A, Giralt D, et al. Characterization of secretomes from a human blood brain barrier endothelial cells in-vitro model after ischemia by stable isotope labeling with aminoacids in cell culture (SILAC). J Proteom. 2016;133:100\u201312.","journal-title":"J Proteom"},{"key":"1283_CR17","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s10020-024-00897-6","volume":"30","author":"RA Loiola","year":"2024","unstructured":"Loiola RA, Hachani J, Duban-Deweer S, Sevin E, Bugno P, Kowalska A, et al. Secretome of brain microvascular endothelial cells promotes endothelial barrier tightness and protects against hypoxia-induced vascular leakage. Mol Med. 2024;30:132.","journal-title":"Mol Med"},{"key":"1283_CR18","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1038\/s41586-025-08584-0","volume":"638","author":"T Guo","year":"2025","unstructured":"Guo T, Steen JA, Mann M. Mass-spectrometry-based proteomics: from single cells to clinical applications. Nature. 2025;638:901\u201311.","journal-title":"Nature"},{"key":"1283_CR19","doi-asserted-by":"publisher","first-page":"107739","DOI":"10.1016\/j.biotechadv.2021.107739","volume":"49","author":"PS Reel","year":"2021","unstructured":"Reel PS, Reel S, Pearson E, Trucco E, Jefferson E. Using machine learning approaches for multi-omics data analysis: a review. Biotechnol Adv. 2021;49:107739.","journal-title":"Biotechnol Adv"},{"key":"1283_CR20","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/s41569-020-00477-1","volume":"18","author":"A Joshi","year":"2021","unstructured":"Joshi A, Rienks M, Theofilatos K, Mayr M. Systems biology in cardiovascular disease: a multiomics approach. Nat Rev Cardiol. 2021;18:313\u201330.","journal-title":"Nat Rev Cardiol"},{"key":"1283_CR21","doi-asserted-by":"publisher","first-page":"1366307","DOI":"10.3389\/fneur.2024.1366307","volume":"15","author":"Y Jiang","year":"2024","unstructured":"Jiang Y, Dang Y, Wu Q, Yuan B, Gao L, You C. Using a k-means clustering to identify novel phenotypes of acute ischemic stroke and development of its clinlabomics models. Front Neurol. 2024;15:1366307.","journal-title":"Front Neurol"},{"key":"1283_CR22","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1161\/01.STR.19.5.604","volume":"19","author":"JC van Swieten","year":"1988","unstructured":"van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19:604\u20137.","journal-title":"Stroke"},{"key":"1283_CR23","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1161\/01.STR.0000027437.22450.BD","volume":"33","author":"JT Wilson","year":"2002","unstructured":"Wilson JT, Hareendran A, Grant M, Baird T, Schulz UG, Muir KW, et al. Improving the assessment of outcomes in stroke: use of a structured interview to assign grades on the modified Rankin scale. Stroke. 2002;33:2243\u20136.","journal-title":"Stroke"},{"key":"1283_CR24","doi-asserted-by":"publisher","first-page":"e2400426","DOI":"10.1002\/advs.202400426","volume":"11","author":"R Li","year":"2024","unstructured":"Li R, Liu Y, Wu J, Chen X, Lu Q, Xia K, et al. Adaptive metabolic responses facilitate Blood-Brain barrier repair in ischemic stroke via BHB-Mediated epigenetic modification of ZO-1 expression. Adv Sci (Weinh). 2024;11:e2400426.","journal-title":"Adv Sci (Weinh)"},{"key":"1283_CR25","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.4103\/1673-5374.385851","volume":"19","author":"T Xu","year":"2024","unstructured":"Xu T, Yang J, Xu Y, Wang X, Gao X, Sun J, et al. Post-acute ischemic stroke hyperglycemia aggravates destruction of the blood-brain barrier. Neural Regen Res. 2024;19:1344\u201350.","journal-title":"Neural Regen Res"},{"key":"1283_CR26","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/s41392-023-01613-2","volume":"8","author":"Y Lu","year":"2023","unstructured":"Lu Y, Yang W, Qi Z, Gao R, Tong J, Gao T, et al. Gut microbe-derived metabolite indole-3-carboxaldehyde alleviates atherosclerosis. Signal Transduct Target Ther. 2023;8:378.","journal-title":"Signal Transduct Target Ther"},{"key":"1283_CR27","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41590-020-00850-9","volume":"22","author":"Y Liu","year":"2021","unstructured":"Liu Y, Zhou N, Zhou L, Wang J, Zhou Y, Zhang T, et al. IL-2 regulates tumor-reactive CD8(+) T cell exhaustion by activating the Aryl hydrocarbon receptor. Nat Immunol. 2021;22:358\u201369.","journal-title":"Nat Immunol"},{"key":"1283_CR28","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.cmet.2023.06.004","volume":"35","author":"C Xue","year":"2023","unstructured":"Xue C, Li G, Zheng Q, Gu X, Shi Q, Su Y, et al. Tryptophan metabolism in health and disease. Cell Metab. 2023;35:1304\u201326.","journal-title":"Cell Metab"},{"key":"1283_CR29","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1007\/s00726-017-2494-2","volume":"49","author":"Y Mart\u00ednez","year":"2017","unstructured":"Mart\u00ednez Y, Li X, Liu G, Bin P, Yan W, M\u00e1s D, et al. The role of methionine on metabolism, oxidative stress, and diseases. Amino Acids. 2017;49:2091\u20138.","journal-title":"Amino Acids"},{"key":"1283_CR30","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/0003-9861(89)90309-3","volume":"268","author":"DJ Carothers","year":"1989","unstructured":"Carothers DJ, Pons G, Patel MS. Dihydrolipoamide dehydrogenase: functional similarities and divergent evolution of the pyridine nucleotide-disulfide oxidoreductases. Arch Biochem Biophys. 1989;268:409\u201325.","journal-title":"Arch Biochem Biophys"},{"key":"1283_CR31","first-page":"168","volume":"33","author":"NN Vettakkorumakankav","year":"1996","unstructured":"Vettakkorumakankav NN, Patel MS. Dihydrolipoamide dehydrogenase: structural and mechanistic aspects. Indian J Biochem Biophys. 1996;33:168\u201376.","journal-title":"Indian J Biochem Biophys"},{"key":"1283_CR32","doi-asserted-by":"publisher","first-page":"14580","DOI":"10.1021\/bi020376k","volume":"41","author":"A Argyrou","year":"2002","unstructured":"Argyrou A, Blanchard JS, Palfey BA. The lipoamide dehydrogenase from mycobacterium tuberculosis permits the direct observation of flavin intermediates in catalysis. Biochemistry. 2002;41:14580\u201390.","journal-title":"Biochemistry"},{"key":"1283_CR33","doi-asserted-by":"publisher","first-page":"4661","DOI":"10.3390\/ijms22094661","volume":"22","author":"AB Salmina","year":"2021","unstructured":"Salmina AB, Kharitonova EV, Gorina YV, Teplyashina EA, Malinovskaya NA, Khilazheva ED, et al. Blood-brain barrier and neurovascular unit in vitro models for studying mitochondria-driven molecular mechanisms of neurodegeneration. Int J Mol Sci. 2021;22:4661.","journal-title":"Int J Mol Sci"},{"key":"1283_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1152\/physrev.00017.2013","volume":"94","author":"CH Chen","year":"2014","unstructured":"Chen CH, Ferreira JC, Gross ER, Mochly-Rosen D. Targeting aldehyde dehydrogenase 2: new therapeutic opportunities. Physiol Rev. 2014;94:1\u201334.","journal-title":"Physiol Rev"},{"key":"1283_CR35","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.bbrc.2012.08.002","volume":"425","author":"WC Lee","year":"2012","unstructured":"Lee WC, Wong HY, Chai YY, Shi CW, Amino N, Kikuchi S, et al. Lipid peroxidation dysregulation in ischemic stroke: plasma 4-HNE as a potential biomarker? Biochem Biophys Res Commun. 2012;425:842\u20137.","journal-title":"Biochem Biophys Res Commun"},{"key":"1283_CR36","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/cr.2013.69","volume":"23","author":"JM Guo","year":"2013","unstructured":"Guo JM, Liu AJ, Zang P, Dong WZ, Ying L, Wang W, et al. ALDH2 protects against stroke by clearing 4-HNE. Cell Res. 2013;23:915\u201330.","journal-title":"Cell Res"},{"key":"1283_CR37","doi-asserted-by":"publisher","first-page":"a041193","DOI":"10.1101\/cshperspect.a041193","volume":"14","author":"S Lautrup","year":"2024","unstructured":"Lautrup S, Hou Y, Fang EF, Bohr VA. Roles of NAD(+) in health and aging. Cold Spring Harb Perspect Med. 2024;14:a041193.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"1283_CR38","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/nrn3257","volume":"13","author":"R Schwarcz","year":"2012","unstructured":"Schwarcz R, Bruno JP, Muchowski PJ, Wu HQ. Kynurenines in the mammalian brain: when physiology Meets pathology. Nat Rev Neurosci. 2012;13:465\u201377.","journal-title":"Nat Rev Neurosci"},{"key":"1283_CR39","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.pneurobio.2009.04.005","volume":"90","author":"R Schwarcz","year":"2010","unstructured":"Schwarcz R, Guidetti P, Sathyasaikumar KV, Muchowski PJ. Of mice, rats and men: revisiting the quinolinic acid hypothesis of huntington\u2019s disease. Prog Neurobiol. 2010;90:230\u201345.","journal-title":"Prog Neurobiol"},{"key":"1283_CR40","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41573-019-0016-5","volume":"18","author":"M Platten","year":"2019","unstructured":"Platten M, Nollen EAA, R\u00f6hrig UF, Fallarino F, Opitz CA. Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond. Nat Rev Drug Discov. 2019;18:379\u2013401.","journal-title":"Nat Rev Drug Discov"},{"key":"1283_CR41","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.3390\/cells9061564","volume":"9","author":"T Biernacki","year":"2020","unstructured":"Biernacki T, Sandi D, Bencsik K, V\u00e9csei L. Kynurenines in the pathogenesis of multiple sclerosis: therapeutic perspectives. Cells. 2020;9:1564.","journal-title":"Cells"},{"key":"1283_CR42","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1111\/j.1471-4159.2008.05241.x","volume":"105","author":"R Owe-Young","year":"2008","unstructured":"Owe-Young R, Webster NL, Mukhtar M, Pomerantz RJ, Smythe G, Walker D, et al. Kynurenine pathway metabolism in human blood-brain-barrier cells: implications for immune tolerance and neurotoxicity. J Neurochem. 2008;105:1346\u201357.","journal-title":"J Neurochem"},{"key":"1283_CR43","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1007\/s11064-010-0187-2","volume":"35","author":"R Brouns","year":"2010","unstructured":"Brouns R, Verkerk R, Aerts T, De Surgeloose D, Wauters A, Scharp\u00e9 S, et al. The role of Tryptophan catabolism along the kynurenine pathway in acute ischemic stroke. Neurochem Res. 2010;35:1315\u201322.","journal-title":"Neurochem Res"},{"key":"1283_CR44","doi-asserted-by":"publisher","first-page":"466","DOI":"10.4103\/NRR.NRR-D-24-00777","volume":"21","author":"C Yao","year":"2026","unstructured":"Yao C, Xie D, Zhang Y, Shen Y, Sun P, Ma Z, et al. Tryptophan metabolism and ischemic stroke: an intricate balance. Neural Regen Res. 2026;21:466\u201377.","journal-title":"Neural Regen Res"},{"key":"1283_CR45","doi-asserted-by":"publisher","first-page":"858","DOI":"10.14336\/AD.2022.0916","volume":"14","author":"Y Huang","year":"2023","unstructured":"Huang Y, Zhao M, Chen X, Zhang R, Le A, Hong M, et al. Tryptophan metabolism in central nervous system diseases: pathophysiology and potential therapeutic strategies. Aging Dis. 2023;14:858\u201378.","journal-title":"Aging Dis"},{"key":"1283_CR46","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.bbi.2024.02.030","volume":"118","author":"HV Sandvig","year":"2024","unstructured":"Sandvig HV, Aam S, Alme KN, Lydersen S, Magne Ueland P, Ulvik A, et al. Neopterin, kynurenine metabolites, and indexes related to vitamin B6 are associated with post-stroke cognitive impairment: the Nor-COAST study. Brain Behav Immun. 2024;118:167\u201377.","journal-title":"Brain Behav Immun"},{"key":"1283_CR47","doi-asserted-by":"publisher","first-page":"100270","DOI":"10.1016\/j.bbih.2021.100270","volume":"15","author":"MK Schuhmann","year":"2021","unstructured":"Schuhmann MK, Kollikowski AM, M\u00e4rz AG, Bieber M, Pham M, Stoll G. Danger-associated molecular patterns are locally released during occlusion in hyper-acute stroke. Brain Behav Immun Health. 2021;15:100270.","journal-title":"Brain Behav Immun Health"},{"key":"1283_CR48","doi-asserted-by":"publisher","first-page":"e16269","DOI":"10.15252\/emmm.202216269","volume":"14","author":"A Simats","year":"2022","unstructured":"Simats A, Liesz A. Systemic inflammation after stroke: implications for post-stroke comorbidities. EMBO Mol Med. 2022;14:e16269.","journal-title":"EMBO Mol Med"},{"key":"1283_CR49","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1046\/j.1471-4159.1996.66030996.x","volume":"66","author":"D Alberati-Giani","year":"1996","unstructured":"Alberati-Giani D, Ricciardi-Castagnoli P, K\u00f6hler C, Cesura AM. Regulation of the kynurenine metabolic pathway by interferon-gamma in murine cloned macrophages and microglial cells. J Neurochem. 1996;66:996\u20131004.","journal-title":"J Neurochem"},{"key":"1283_CR50","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1089\/107999003322277829","volume":"23","author":"CM Robinson","year":"2003","unstructured":"Robinson CM, Shirey KA, Carlin JM. Synergistic transcriptional activation of indoleamine dioxygenase by IFN-gamma and tumor necrosis factor-alpha. J Interferon Cytokine Res. 2003;23:413\u201321.","journal-title":"J Interferon Cytokine Res"},{"key":"1283_CR51","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s00702-011-0681-y","volume":"119","author":"Y M\u00e1ndi","year":"2012","unstructured":"M\u00e1ndi Y, V\u00e9csei L. The kynurenine system and immunoregulation. J Neural Transm (Vienna). 2012;119:197\u2013209.","journal-title":"J Neural Transm (Vienna)"},{"key":"1283_CR52","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.biocel.2008.01.005","volume":"41","author":"HJ Ball","year":"2009","unstructured":"Ball HJ, Yuasa HJ, Austin CJD, Weiser S, Hunt NH. Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathway. Int J Biochem Cell Biol. 2009;41:467\u201371.","journal-title":"Int J Biochem Cell Biol"},{"key":"1283_CR53","doi-asserted-by":"publisher","first-page":"eaaf9794","DOI":"10.1126\/science.aaf9794","volume":"357","author":"I Cervenka","year":"2017","unstructured":"Cervenka I, Agudelo LZ, Ruas JL, Kynurenines. Tryptophan\u2019s metabolites in exercise, inflammation, and mental health. Science. 2017;357:eaaf9794.","journal-title":"Science"},{"key":"1283_CR54","doi-asserted-by":"publisher","first-page":"117864691769193","DOI":"10.1177\/1178646917691938","volume":"10","author":"AA Badawy","year":"2017","unstructured":"Badawy AA. Kynurenine pathway of Tryptophan metabolism: regulatory and functional aspects. Int J Tryptophan Res. 2017;10:1178646917691938.","journal-title":"Int J Tryptophan Res"},{"key":"1283_CR55","doi-asserted-by":"publisher","first-page":"C252","DOI":"10.1152\/ajpcell.00151.2018","volume":"316","author":"DN Edwards","year":"2019","unstructured":"Edwards DN, Bix GJ. Roles of blood-brain barrier integrins and extracellular matrix in stroke. Am J Physiol Cell Physiol. 2019;316:C252\u201363.","journal-title":"Am J Physiol Cell Physiol"},{"key":"1283_CR56","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1007\/s11011-024-01451-3","volume":"40","author":"Y Jiang","year":"2025","unstructured":"Jiang Y, Wu Q, Dang Y, Peng L, Meng L, You C. Untargeted metabolomics unveils critical metabolic signatures in novel phenotypes of acute ischemic stroke. Metab Brain Dis. 2025;40:130.","journal-title":"Metab Brain Dis"},{"key":"1283_CR57","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1161\/01.STR.0000153008.60517.ab","volume":"36","author":"M Endres","year":"2005","unstructured":"Endres M, Ahmadi M, Kruman I, Biniszkiewicz D, Meisel A, Gertz K. Folate deficiency increases postischemic brain injury. Stroke. 2005;36:321\u20135.","journal-title":"Stroke"},{"key":"1283_CR58","doi-asserted-by":"publisher","first-page":"a004994","DOI":"10.1101\/cshperspect.a004994","volume":"3","author":"ID Campbell","year":"2011","unstructured":"Campbell ID, Humphries MJ. Integrin structure, activation, and interactions. Cold Spring Harb Perspect Biol. 2011;3:a004994.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"1283_CR59","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.biotechadv.2017.11.004","volume":"36","author":"LA Rocha","year":"2018","unstructured":"Rocha LA, Learmonth DA, Sousa RA, Salgado AJ. \u03b1v\u03b23 and \u03b15\u03b21 integrin-specific ligands: from tumor angiogenesis inhibitors to vascularization promoters in regenerative medicine? Biotechnol Adv. 2018;36:208\u201327.","journal-title":"Biotechnol Adv"},{"key":"1283_CR60","doi-asserted-by":"publisher","first-page":"113042","DOI":"10.1016\/j.expneurol.2019.113042","volume":"321","author":"L Wang","year":"2019","unstructured":"Wang L, Zhang X, Liu X, Feng G, Fu Y, Milner R, et al. Overexpression of \u03b15\u03b21 integrin and angiopoietin-1 co-operatively promote blood-brain barrier integrity and angiogenesis following ischemic stroke. Exp Neurol. 2019;321:113042.","journal-title":"Exp Neurol"},{"key":"1283_CR61","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.expneurol.2012.06.005","volume":"237","author":"L Li","year":"2012","unstructured":"Li L, Welser-Alves J, van der Flier A, Boroujerdi A, Hynes RO, Milner R. An angiogenic role for the \u03b15\u03b21 integrin in promoting endothelial cell proliferation during cerebral hypoxia. Exp Neurol. 2012;237:46\u201354.","journal-title":"Exp Neurol"},{"key":"1283_CR62","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.expneurol.2011.10.017","volume":"233","author":"L Li","year":"2012","unstructured":"Li L, Liu F, Welser-Alves JV, McCullough LD, Milner R. Upregulation of fibronectin and the \u03b15\u03b21 and \u03b1v\u03b23 integrins on blood vessels within the cerebral ischemic penumbra. Exp Neurol. 2012;233:283\u201391.","journal-title":"Exp Neurol"},{"key":"1283_CR63","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1021\/cn300197y","volume":"4","author":"GJ Bix","year":"2013","unstructured":"Bix GJ. Perlecan domain V therapy for stroke: a beacon of hope? ACS Chem Neurosci. 2013;4:370\u20134.","journal-title":"ACS Chem Neurosci"},{"key":"1283_CR64","doi-asserted-by":"publisher","first-page":"3005","DOI":"10.1172\/JCI46358","volume":"121","author":"B Lee","year":"2011","unstructured":"Lee B, Clarke D, Al Ahmad A, Kahle M, Parham C, Auckland L, et al. Perlecan domain V is neuroprotective and proangiogenic following ischemic stroke in rodents. J Clin Invest. 2011;121:3005\u201323.","journal-title":"J Clin Invest"},{"key":"1283_CR65","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1038\/jcbfm.2011.99","volume":"31","author":"T Osada","year":"2011","unstructured":"Osada T, Gu YH, Kanazawa M, Tsubota Y, Hawkins BT, Spatz M, et al. Interendothelial claudin-5 expression depends on cerebral endothelial cell-matrix adhesion by \u03b2(1)-integrins. J Cereb Blood Flow Metab. 2011;31:1972\u201385.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1283_CR66","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12987-022-00404-1","volume":"20","author":"SSE Nielsen","year":"2023","unstructured":"Nielsen SSE, Holst MR, Langthaler K, Christensen SC, Bruun EH, Brodin B, et al. Apicobasal transferrin receptor localization and trafficking in brain capillary endothelial cells. Fluids Barriers CNS. 2023;20:2.","journal-title":"Fluids Barriers CNS"},{"key":"1283_CR67","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/jnr.490180206","volume":"18","author":"JB Fishman","year":"1987","unstructured":"Fishman JB, Rubin JB, Handrahan JV, Connor JR, Fine RE. Receptor-mediated transcytosis of transferrin across the blood-brain barrier. J Neurosci Res. 1987;18:299\u2013304.","journal-title":"J Neurosci Res"},{"key":"1283_CR68","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.mcn.2016.08.009","volume":"76","author":"M Hersom","year":"2016","unstructured":"Hersom M, Helms HC, Pretzer N, Goldeman C, Jensen AI, Severin G, et al. Transferrin receptor expression and role in transendothelial transport of transferrin in cultured brain endothelial monolayers. Mol Cell Neurosci. 2016;76:59\u201367.","journal-title":"Mol Cell Neurosci"},{"key":"1283_CR69","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.bbrc.2018.10.185","volume":"507","author":"L Yang","year":"2018","unstructured":"Yang L, Wang D, Wang XT, Lu YP, Zhu L. The roles of hypoxia-inducible Factor-1 and iron regulatory protein 1 in iron uptake induced by acute hypoxia. Biochem Biophys Res Commun. 2018;507:128\u201335.","journal-title":"Biochem Biophys Res Commun"},{"key":"1283_CR70","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.freeradbiomed.2018.07.018","volume":"133","author":"K Hirota","year":"2019","unstructured":"Hirota K. An intimate crosstalk between iron homeostasis and oxygen metabolism regulated by the hypoxia-inducible factors (HIFs). Free Radic Biol Med. 2019;133:118\u201329.","journal-title":"Free Radic Biol Med"},{"key":"1283_CR71","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1007\/s11064-023-04096-3","volume":"49","author":"L Zhang","year":"2024","unstructured":"Zhang L, Bai XY, Sun KY, Li X, Zhang ZQ, Liu YD, et al. A new perspective in the treatment of ischemic stroke: ferroptosis. Neurochem Res. 2024;49:815\u201333.","journal-title":"Neurochem Res"},{"key":"1283_CR72","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s10571-022-01196-6","volume":"43","author":"Y Xu","year":"2023","unstructured":"Xu Y, Li K, Zhao Y, Zhou L, Liu Y, Zhao J. Role of ferroptosis in stroke. Cell Mol Neurobiol. 2023;43:205\u201322.","journal-title":"Cell Mol Neurobiol"},{"key":"1283_CR73","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/s41419-023-05688-1","volume":"14","author":"H Zheng","year":"2023","unstructured":"Zheng H, Guo X, Kang S, Li Z, Tian T, Li J, et al. Cdh5-mediated Fpn1 deletion exerts neuroprotective effects during the acute phase and inhibitory effects during the recovery phase of ischemic stroke. Cell Death Dis. 2023;14:161.","journal-title":"Cell Death Dis"},{"key":"1283_CR74","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S0306-4522(00)00317-1","volume":"100","author":"SI Chi","year":"2000","unstructured":"Chi SI, Wang CK, Chen JJ, Chau LY, Lin TN. Differential regulation of H- and L-ferritin messenger RNA subunits, ferritin protein and iron following focal cerebral ischemia-reperfusion. Neuroscience. 2000;100:475\u201384.","journal-title":"Neuroscience"},{"key":"1283_CR75","doi-asserted-by":"publisher","first-page":"123625","DOI":"10.1016\/j.lfs.2025.123625","volume":"372","author":"L Wang","year":"2025","unstructured":"Wang L, Liu HR, Liu HQ, Li XS, Tang TT, Wang KJ, et al. SETD1B promotes brain cell ferroptosis in ischemic stroke mice via increasing H3K4me3 enrichment on the Tfrc promoter. Life Sci. 2025;372:123625.","journal-title":"Life Sci"},{"key":"1283_CR76","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1074\/jbc.271.6.3272","volume":"271","author":"KY Chung","year":"1996","unstructured":"Chung KY, Agarwal A, Uitto J, Mauviel A. An AP-1 binding sequence is essential for regulation of the human alpha2(I) collagen (COL1A2) promoter activity by transforming growth factor-beta. J Biol Chem. 1996;271:3272\u20138.","journal-title":"J Biol Chem"},{"key":"1283_CR77","doi-asserted-by":"publisher","first-page":"4316","DOI":"10.1074\/jbc.272.7.4316","volume":"272","author":"M Dolan","year":"1997","unstructured":"Dolan M, Horchar T, Rigatti B, Hassell JR. Identification of sites in domain I of Perlecan that regulate Heparan sulfate synthesis. J Biol Chem. 1997;272:4316\u201322.","journal-title":"J Biol Chem"},{"key":"1283_CR78","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1083\/jcb.200108159","volume":"155","author":"I Okamoto","year":"2001","unstructured":"Okamoto I, Kawano Y, Murakami D, Sasayama T, Araki N, Miki T, et al. Proteolytic release of CD44 intracellular domain and its role in the CD44 signaling pathway. J Cell Biol. 2001;155:755\u201362.","journal-title":"J Cell Biol"}],"container-title":["Molecular Brain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13041-026-01283-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13041-026-01283-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13041-026-01283-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T11:02:49Z","timestamp":1774436569000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13041-026-01283-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,16]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1283"],"URL":"https:\/\/doi.org\/10.1186\/s13041-026-01283-5","relation":{},"ISSN":["1756-6606"],"issn-type":[{"value":"1756-6606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,16]]},"assertion":[{"value":"7 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This observational study was conducted in accordance with the principles of the 2013 Declaration of Helsinki. The study protocol was approved by the Ethics Committee of The Second Hospital & Clinical Medical School, Lanzhou University (IRB numbers: 2023\u00a0A-034 and 2024\u00a0A-331), and has been registered with the Chinese Clinical Trial Registry (ChiCTR) under the registration number ChiCTR2500107343.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the authors agree to publication in the journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19"}}